Subcutaneous tocilizumab may be less effective than intravenous tocilizumab in the treatment of juvenile idiopathic arthritis-Associated uveitis

  1. Quesada-Masachs, E.
  2. Caballero, C.M.
Aldizkaria:
Journal of Rheumatology

ISSN: 1499-2752,  0315-162X

Argitalpen urtea: 2017

Alea: 44

Zenbakia: 2

Orrialdeak: 260-261

Mota: Gutuna

DOI: 10.3899/JRHEUM.160908 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus